-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Exponent, Lowers Price Target to $72

Benzinga·07/31/2026 21:28:18
Listen to the news
UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and lowers the price target from $75 to $72.